Oncology Generics Medicines
Buyers
Value
£29,082,301
Suppliers
- Waverley Pharma Europe Limited
- Consilient Health Ltd
- Pfizer Ltd
- Accord Healthcare Ltd
- medac Pharma LLP
- Baxter Healthcare Ltd
- Fresenius Kabi Limited
- Ipsen Limited
- Rosemont Pharmaceuticals Ltd
- Ranbaxy (UK) Ltd
- Teva UK Limited
- Novartis Pharmaceuticals UK Ltd
- Zentiva Pharma UK Ltd
- Sandoz Ltd
- Neon Healthcare Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Napp Pharmaceuticals
- DRUGSRUS LTD
- Glenmark Pharmaceuticals Europe Ltd
- hameln pharmaceuticals ltd
- Kent Pharmaceuticals Ltd
- Martindale Pharma
- Morningside Pharmaceuticals Limited
- Mylan
- Selective Supplies Ltd
- Tillomed Laboratories ltd
- Altan Pharma Ltd.
- ASPEN PHARMACARE UK LIMITED
Classifications
- Pharmaceutical products
Tags
- award
- contract
Published
3 years ago
Description
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
+44 1312252525
Timeline complete
Complete